IAG
GILD icon

Investment Advisory Group’s Gilead Sciences GILD Stock Holding History

Investment Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$280K Buy
2,009
+33
+2% +$4.62K 0.07% 157
2025
Q4 		$243K Buy
1,976
+45
+2% +$5.47K 0.06% 167
2025
Q3 		$214K Hold
1,931
– – 0.06% 180
2025
Q2 		$214K Sell
1,931
-14
-0.7% -$1.49K 0.06% 167
2025
Q1 		$218K Buy
+1,945
New +$201K 0.07% 158

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Investment Advisory Group's GILD Position: Q1 2026 in Review

Investment Advisory Group increased its Gilead Sciences (GILD) stake by 1.7% in Q1 2026, buying an estimated $4.62K and bringing the position to 2,009 shares worth $280K. The position accounts for 0.07% of the portfolio, ranked #157.

Investment Advisory Group first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Investment Advisory Group held 2,009 shares of Gilead Sciences worth $280K as of Q1 2026.
  • Investment Advisory Group bought 33 Gilead Sciences shares in Q1 2026, an estimated $4.62K.
  • Gilead Sciences made up 0.07% of Investment Advisory Group's portfolio in Q1 2026, its #157 holding.
  • Investment Advisory Group first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Investment Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.